Unicycive Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.58

+0.47 (+7.69%)

As of Mar 31, 10:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target -4.7% upside

Low Target $3.63

Average Target $6.27

High Target $7.20

Current Price $6.58

Current
$6.58

Target
$6.27

$3.63 $6.27 avg $7.20

Scenario Analysis

Bear Case

$3.63

-44.8%

Low target

Base Case

$6.27

-4.7%

Avg target

Bull Case

$7.20

+9.4%

High target

Risk/Reward

0.2x

Unfavorable

Price in Context

52-Week High

$11.00

-40.2% from high

52-Week Low

$3.71

+77.4% from low

Target vs 52W High

$6.27

-43.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%